These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 13406548)

  • 1. On the Fuchs cancer test: species-specific proteolysis of fibrin by serum.
    PEACOCK AC; HIGHSMITH EM
    J Natl Cancer Inst; 1957 Feb; 18(2):285-9. PubMed ID: 13406548
    [No Abstract]   [Full Text] [Related]  

  • 2. [Enzymatic fibrin-splitting test for early diagnosis of cancer].
    NITSCHE P
    Arztl Forsch; 1958 Jun; 12(6):I/289-95. PubMed ID: 13545082
    [No Abstract]   [Full Text] [Related]  

  • 3. The cancer recognition (CARE) antibody test.
    Thornthwaite JT; McDuffee EC; Harris RB; Secor McVoy JR; Lane IW
    Cancer Lett; 2004 Dec; 216(2):227-41. PubMed ID: 15533599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is the Bolen test specific for cancer].
    HELLER H
    Z Gesamte Inn Med; 1957 Oct; 12(19):900-5. PubMed ID: 13531271
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer biomarkers: knowing the present and predicting the future.
    Chatterjee SK; Zetter BR
    Future Oncol; 2005 Feb; 1(1):37-50. PubMed ID: 16555974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
    Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
    J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of D-dimer measurement for cancer in patients with deep vein thrombosis.
    Falanga A
    Haematologica; 2005 Feb; 90(2):149. PubMed ID: 15713577
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer proteomics: many technologies, one goal.
    Conrads TP; Hood BL; Petricoin EF; Liotta LA; Veenstra TD
    Expert Rev Proteomics; 2005 Oct; 2(5):693-703. PubMed ID: 16209649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Beard Anthrone Test: a bio-chemical test for cancer.
    NAVARRO MD; NAVARRO RP
    J Philipp Med Assoc; 1957 Oct; 33(10):740-6. PubMed ID: 13481863
    [No Abstract]   [Full Text] [Related]  

  • 12. Advances, challenges, and limitations in serum-proteome-based cancer diagnosis.
    Ebert MP; Korc M; Malfertheiner P; Röcken C
    J Proteome Res; 2006 Jan; 5(1):19-25. PubMed ID: 16396491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The suitability of Herrmann's fermentation (methylene blue) test as a cancer test].
    BOHLIG H; SCHETTLER G
    Z Gesamte Inn Med; 1955 Mar; 10(5):230-3. PubMed ID: 14374805
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhanced engraftment of mesenchymal stem cells in a cutaneous wound model by culture in allogenic species-specific serum and administration in fibrin constructs.
    Gregory CA; Reyes E; Whitney MJ; Spees JL
    Stem Cells; 2006 Oct; 24(10):2232-43. PubMed ID: 16763199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' anxiety and expectations: how they influence family physicians' decisions to order cancer screening tests.
    Haggerty J; Tudiver F; Brown JB; Herbert C; Ciampi A; Guibert R
    Can Fam Physician; 2005 Dec; 51(12):1658-9. PubMed ID: 16926946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional culture system as a model for studying cancer cell invasion capacity and anticancer drug sensitivity.
    Doillon CJ; Gagnon E; Paradis R; Koutsilieris M
    Anticancer Res; 2004; 24(4):2169-77. PubMed ID: 15330157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer screening in general practice.
    Fahridin S; Britt H
    Aust Fam Physician; 2009 Apr; 38(4):187. PubMed ID: 19350065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Data mining techniques for cancer detection using serum proteomic profiling.
    Li L; Tang H; Wu Z; Gong J; Gruidl M; Zou J; Tockman M; Clark RA
    Artif Intell Med; 2004 Oct; 32(2):71-83. PubMed ID: 15364092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A truth serum for cancer--microRNAs have major potential as cancer biomarkers.
    Chin LJ; Slack FJ
    Cell Res; 2008 Oct; 18(10):983-4. PubMed ID: 18833286
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum lactic dehydrogenase in cancer patients.
    HILL JH
    J Natl Cancer Inst; 1957 Feb; 18(2):307-13. PubMed ID: 13406551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.